Nupr1 deletion protects against glucose intolerance by increasing beta cell mass

Diabetologia

Volumn 56, Issue 11, 2013, Pages 2477-2486

  Barbosa Sampaio, Helena C ^a   Liu, Bo ^a   Drynda, Robert ^a   De Ledesma, Ana M Rodriguez ^a   King, Aileen J ^a   Bowe, James E ^a   Malicet, Cédric ^b   Iovanna, Juan L ^b   Jones, Peter M ^a   Persaud, Shanta J ^a   Muller, Dany S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b INSERM   (France)

Author keywords

Beta cell mass; Glucose homeostasis; High fat diet; Islets of Langerhans; NUPR1

Indexed keywords

CYCLIN A2; GLUCOSE; NUCLEAR PROTEIN; NUCLEAR PROTEIN TRANSCRIPTION REGULATOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA CELL MASS; CCNA2 GENE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELLULAR PARAMETERS; CONTROLLED STUDY; FEMALE; GENE; GENE DELETION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUPR1 GENE; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; TCF19 GENE;

ANIMALS; BLOTTING, WESTERN; DNA-BINDING PROTEINS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-SECRETING CELLS; MALE; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS;

EID: 84885859075     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3006-x     Document Type: Article

References (42)

1. Mallo GV, Fiedler F, Calvo EL et al (1997) Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development, and regeneration, and which promotes cellular growth. J Biol Chem 272:32360-32369
2. Vasseur S, Folch-Puy E, Hlouschek V et al (2004) p8 improves pancreatic response to acute pancreatitis by enhancing the expression of the anti-inflammatory protein pancreatitis-associated protein I. J Biol Chem 279:7199-7207
3. Jiang YF, Vaccaro MI, Fiedler F, Calvo EL, Iovanna JL (1999) Lipopolysaccharides induce p8 mRNA expression in vivo and in vitro. Biochem Biophys Res Commun 260:686-690
4. Vasseur S, Hoffmeister A, Garcia-Montero A et al (2003) Mice with targeted disruption of p8 gene show increased sensitivity to lipopolysaccharide and DNA microarray analysis of livers reveals an aberrant gene expression response. BMC Gastroenterol 3:25
5. Encinar JA, Mallo GV, Mizyrycki C et al (2001) Human p8 is a HMG-I/Y-like protein with DNA binding activity enhanced by phosphorylation. J Biol Chem 276:2742-2751
6. Malicet C, Giroux V, Vasseur S, Dagorn JC, Neira JL, Iovanna JL (2006) Regulation of apoptosis by the p8/prothymosin alpha complex. Proc Natl Acad Sci USA 103:2671-2676
7. Vasseur S, Vidal Mallo G, Fiedler F et al (1999) Cloning and expression of the human p8, a nuclear protein with mitogenic activity. Eur J Biochem 259:670-675
8. Vasseur S, Hoffmeister A, Garcia-Montero A et al (2002) p8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis. Oncogene 21:1685-1694
9. Päth G, Opel A, Knoll A, Seufert J (2004) Nuclear protein p8 is associated with glucose-induced pancreatic beta-cell growth. Diabetes 53(Suppl 1):S82-S85
10. Pellerito O, Calvaruso G, Portanova P et al (2010) The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis. Mol Pharmacol 77:854-863
11. Päth G, Opel A, Gehlen M et al (2006) Glucose-dependent expansion of pancreatic beta-cells by the protein p8 in vitro and in vivo. Am J Physiol Endocrinol Metab 291:E1168-E1176
12. Papadimitriou A, King AJF, Jones PM, Persaud SJ (2007) Anti-apoptotic effects of arachidonic acid and prostaglandin E2 in pancreatic beta-cells. Cell Physiol Biochem 20:607-616
13. Jones PM, Salmon DM, Howell SL (1988) Protein phosphorylation in electrically permeabilized islets of Langerhans. Effects of Ca2+, cyclic AMP, a phorbol ester and noradrenaline. Biochem J 254:397-403
14. Yoshizumi M, Wang H, Hsieh C-M, Sibinga NES, Perrella MA, Lee M-E (1997) Down-regulation of the cyclin a promoter by transforming growth factor-β1 is associated with a reduction in phosphorylated activating transcription factor-1 and cyclic AMP-responsive element-binding protein. J Biol Chem 272:22259-22264
15. Huang GC, Zhao M, Jones P et al (2004) The development of new density gradient media for purifying human islets and islet-quality assessments. Transplantation 77:143-145
16. Muller D, Huang GC, Amiel S, Jones PM, Persaud SJ (2006) Identification of insulin signaling elements in human beta-cells: autocrine regulation of insulin gene expression. Diabetes:2835-2842
17. Persaud SJ, Liu B, Sampaio HB, Jones PM, Muller DS (2011) Calcium/calmodulin-dependent kinase IV controls glucose-induced Irs2 expression in mouse beta cells via activation of cAMP response element-binding protein. Diabetologia 54:1109-1120
18. Muller, D S, Jones, P M, Persaud, SJ (2007) Expression of a potent anti-apoptotic protein in MIN6 b-cells using METAFECTENE PRO [Internet]. Biontex. Available from: www.biontex.com/con-4-6-4/cms/upload/pdf/Muller-MP-en. pdf. Accessed 12 July 2013
19. Muller D, Jones PM, Persaud SJ (2006) Autocrine anti-apoptotic and proliferative effects of insulin in pancreatic beta-cells. FEBS Lett 580:6977-6980
20. Song W-J, Schreiber WE, Zhong E et al (2008) Exendin-4 stimulation of cyclin A2 in beta-cell proliferation. Diabetes 57:2371-2381
21. Ku DH, Chang CD, Koniecki J et al (1991) A new growth-regulated complementary DNA with the sequence of a putative trans-activating factor. Cell Growth Differ 2:179-186
22. Saltiel AR (2001) New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517-529
23. Butler AE, Janson J, Soeller WC, Butler PC (2003) Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52:2304-2314
24. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
25. Plachot C, Movassat J, Portha B (2001) Impaired beta-cell regeneration after partial pancreatectomy in the adult Goto-Kakizaki rat, a spontaneous model of type II diabetes. Histochem Cell Biol 116:131-139
26. Portha B (2005) Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diabetes Metab Res Rev 21:495-504
27. Sherr CJ (1995) Mammalian G1 cyclins and cell cycle progression. Proc Assoc Am Physicians 107:181-186
28. Sherr CJ, Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163
29. Garcia-Montero A, Vasseur S, Mallo GV, Soubeyran P, Dagorn JC, Iovanna JL (2001) Expression of the stress-induced p8 mRNA is transiently activated after culture medium change. Eur J Cell Biol 80:720-725
30. Taïeb D, Malicet C, Garcia S et al (2005) Inactivation of stress protein p8 increases murine carbon tetrachloride hepatotoxicity via preserved CYP2E1 activity. Hepatology 42:176-182
31. Carracedo A, Egia A, Guzmán M, Velasco G (2006) p8 Upregulation sensitizes astrocytes to oxidative stress. FEBS Lett 580:1571-1575
32. Valacco MP, Varone C, Malicet C, Cánepa E, Iovanna JL, Moreno S (2006) Cell growth-dependent subcellular localization of p8. J Cell Biochem 97:1066-1079
33. Kallwellis K, Grempler R, Günther S, Päth G, Walther R (2006) Tumor necrosis factor alpha induces the expression of the nuclear protein p8 via a novel NF kappaB binding site within the promoter. Horm Metab Res 38:570-574
34. Passe CMM, Cooper G, Quirk CC (2006) The murine p8 gene promoter is activated by activating transcription factor 4 (ATF4) in the gonadotrope-derived LbetaT2 cell line. Endocrine 30:81-91
35. Averous J, Lambert-Langlais S, Cherasse Y et al (2011) Amino acid deprivation regulates the stress-inducible gene p8 via the GCN2/ATF4 pathway. Biochem Biophys Res Commun 413:24-29
36. Pommier RM, Gout J, Vincent DF et al (2012) The human NUPR1/P8 gene is transcriptionally activated by transforming growth factor β via the SMAD signalling pathway. Biochem J 445(2):285-293
37. Goruppi S, Kyriakis JM (2004) The pro-hypertrophic basic helix-loop-helix protein p8 is degraded by the ubiquitin/proteasome system in a protein kinase B/Akt- and glycogen synthase kinase-3-dependent manner, whereas endothelin induction of p8 mRNA and renal mesangial cell hypertrophy require NFAT4. J Biol Chem 279:20950-20958
38. Liu B, Barbosa-Sampaio H, Jones PM, Persaud SJ, Muller DS (2012) The CaMK4/CREB/IRS-2 cascade stimulates proliferation and inhibits apoptosis of β-cells. PLoS One 7(9):e45711
39. Malicet C, Lesavre N, Vasseur S, Iovanna JL (2003) p8 inhibits the growth of human pancreatic cancer cells and its expression is induced through pathways involved in growth inhibition and repressed by factors promoting cell growth. Mol Cancer 2:37
40. Sambasivan R, Cheedipudi S, Pasupuleti N, Saleh A, Pavlath GK, Dhawan J (2009) The small chromatin-binding protein p8 coordinates the association of anti-proliferative and pro-myogenic proteins at the myogenin promoter. J Cell Sci 122(Pt 19):3481-3491
41. Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806
42. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846